Clinical Trials Directory

Trials / Completed

CompletedNCT00002170

A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)

A Pilot, Phase II, Randomized, Placebo-Controlled Study to Determine the Effects of Viracept on the Clinical Outcome of Disseminated Mycobacterium Avium Complex Disease (MAC) in AIDS Patients Who Are Receiving Standard Acute Treatment for This Opportunistic Infection

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
—
Sponsor
Agouron Pharmaceuticals · Industry
Sex
All
Age
13 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are being treated for MAC.

Conditions

Interventions

TypeNameDescription
DRUGNelfinavir mesylate

Timeline

First posted
2001-08-31
Last updated
2005-06-24

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00002170. Inclusion in this directory is not an endorsement.